{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:21:07Z","timestamp":1790774467786,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R21HL133694"],"award-info":[{"award-number":["R21HL133694"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute, National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Health and Human Services","award":["HHSN268201700001I"],"award-info":[{"award-number":["HHSN268201700001I"]}]},{"name":"Department of Health and Human Services","award":["HHSN268201700003I"],"award-info":[{"award-number":["HHSN268201700003I"]}]},{"name":"Department of Health and Human Services","award":["HHSN268201700005I"],"award-info":[{"award-number":["HHSN268201700005I"]}]},{"name":"Department of Health and Human Services","award":["HHSN268201700004I"],"award-info":[{"award-number":["HHSN268201700004I"]}]},{"name":"Department of Health and Human Services","award":["HHSN2682017000021"],"award-info":[{"award-number":["HHSN2682017000021"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.atherosclerosis.2018.04.042","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T13:14:41Z","timestamp":1525094081000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7179-718X","authenticated-orcid":false,"given":"Ning","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana H.","family":"Ballew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1210-7115","authenticated-orcid":false,"given":"Bernard","family":"Jaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron C.","family":"Hoogeveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Richey","family":"Sharrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Folsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Selvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib1","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2337\/diacare.26.12.3333","article-title":"Peripheral arterial disease in people with diabetes","volume":"26","author":"American Diabetes Association","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib2","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib4","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.jacc.2012.08.983","article-title":"Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000-2008","volume":"60","author":"Jones","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib5","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(13)61576-7","article-title":"The global pandemic of peripheral artery disease","volume":"382","author":"Hirsch","year":"2013","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2018.04.042_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur. J. Vasc. Endovasc. Surg.: Off. J. Europ. Soc. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib7","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.2337\/dc17-S013","article-title":"10. Microvascular complications and foot care","volume":"40","author":"American Diabetes Association","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib8","first-page":"103","article-title":"Adherence to foot self-care in diabetes mellitus patients","volume":"68","author":"Rezende Neta","year":"2015","journal-title":"Rev. Bras. Enferm."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2337\/diacare.29.04.06.dc05-2018","article-title":"HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study","volume":"29","author":"Selvin","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109506","article-title":"The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes","volume":"9","author":"Lind","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib11","first-page":"477","article-title":"Hereditary spherocytosis and other hemolytic anomalies distort diabetic control by glycated hemoglobin","volume":"52","author":"Kutter","year":"2006","journal-title":"Clin. Lab."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14737159.8.1.9","article-title":"1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions","volume":"8","author":"Dungan","year":"2008","journal-title":"Expert Rev. Mol. Diagn"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1932296814567227","article-title":"Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes","volume":"9","author":"Danese","year":"2015","journal-title":"J.\u00a0Diabetes. Sci. Technol"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2337\/db15-0607","article-title":"Association of 1,5-anhydroglucitol with cardiovascular disease and mortality","volume":"65","author":"Selvin","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.115.015415","article-title":"Fructosamine and glycated albumin and the risk of cardiovascular outcomes and death","volume":"132","author":"Selvin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The atherosclerosis risk in Communities (ARIC) study: design and objectives","volume":"129","author":"The ARIC investigators","year":"1989","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1753-0407.2010.00070.x","article-title":"Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study","volume":"2","author":"Selvin","year":"2010","journal-title":"J.\u00a0Diabetes"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S2213-8587(13)70199-2","article-title":"Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","volume":"2","author":"Selvin","year":"2014","journal-title":"Lancet. Diabetes. Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cca.2011.01.007","article-title":"Comparison of two assays for serum 1,5-anhydroglucitol","volume":"412","author":"Selvin","year":"2011","journal-title":"CCA (Clin. Chim. Acta)"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1373\/clinchem.2010.150250","article-title":"Determining stability of stored samples retrospectively: the validation of glycated albumin","volume":"57","author":"Nathan","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib21","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1093\/clinchem\/34.12.2545","article-title":"Stability of serum fructosamine during storage","volume":"34","author":"Koskinen","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ahj.2005.03.055","article-title":"Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"151","author":"Astor","year":"2006","journal-title":"Am. Heart J."},{"issue":"Suppl C","key":"10.1016\/j.atherosclerosis.2018.04.042_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/eurheartj\/10.suppl_C.13","article-title":"Improving the detection and diagnosis of congestive heart failure","volume":"10","author":"Wilhelmsen","year":"1989","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib25","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/oxfordjournals.eurheartj.a062365","article-title":"Cardiac and pulmonary causes of dyspnoea\u2013validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913","volume":"8","author":"Eriksson","year":"1987","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib26","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/CIRCULATIONAHA.114.014145","article-title":"Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"131","author":"Soliman","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2005111204","article-title":"Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study","volume":"18","author":"Wattanakit","year":"2007","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/1358863X14559589","article-title":"Development of administrative data algorithms to identify patients with critical limb ischemia","volume":"19","author":"Bekwelem","year":"2014","journal-title":"Vasc. Med."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diaclin.34.1.3","article-title":"Standards of medical care in diabetes-2016 abridged for primary care providers","volume":"34","author":"American Diabetes Association","year":"2016","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib30","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/dc06-1910","article-title":"1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes","volume":"29","author":"Dungan","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/01621459.1962.10480664","article-title":"An efficient method of estimating seemingly unrelated regressions and tests for aggregation bias","volume":"57","author":"Zellner","year":"1962","journal-title":"J.\u00a0Am. Stat. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib32","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2337\/dc13-2303","article-title":"Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial","volume":"37","author":"Althouse","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib33","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2337\/diacare.28.8.1981","article-title":"Relationship between HbA1c level and peripheral arterial disease","volume":"28","author":"Muntner","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2337\/diacare.19.5.450","article-title":"GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study","volume":"19","author":"Park","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib35","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s001250051249","article-title":"Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study","volume":"42","author":"de Vegt","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib36","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.numecd.2016.08.006","article-title":"Low fructosamine and mortality - a long term follow-up of 215,011 non-diabetic subjects in the Swedish AMORIS study","volume":"26","author":"Malmstrom","year":"2016","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/004947559802800105","article-title":"Monitoring diabetic control in developing countries: a review of glycated haemoglobin and fructosamine assays","volume":"28","author":"Rahlenbeck","year":"1998","journal-title":"Trop. Doct."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib38","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.3390\/ijms160511294","article-title":"A\u00a0review of the pathophysiology and potential biomarkers for peripheral artery disease","volume":"16","author":"Krishna","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UKPDS Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"DCCT Research Group","year":"1993","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1573399811666150701143112","article-title":"HbA1c, fructosamine, and glycated albumin in the detection of dysglycaemic conditions","volume":"12","author":"Ribeiro","year":"2016","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.atherosclerosis.2018.04.042_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1358863X08089277","article-title":"National health care costs of peripheral arterial disease in the Medicare population","volume":"13","author":"Hirsch","year":"2008","journal-title":"Vasc. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018302272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018302272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T11:30:16Z","timestamp":1661081416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018302272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":43,"alternative-id":["S0021915018302272"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.04.042","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}